Not logged in Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
RELAY: Final Overall Survival for Erlotinib Plus Ramucirumab or Placebo in Untreated, EGFR-Mutated Metastatic NSCLC Nakagawa, Kazuhiko; Garon, Edward B.; Seto, Takashi; Nishio, Makoto; Aix, Santiago Ponce; Paz-Ares, Luis; Chiu, Chao-Hua; Park, Keunchil; Novello, Silvia; Nadal, Ernest; Nishino, Kazumi; Yoh, Kiyotaka; Shih, Jin-Yuan; Chik, Jeannie Y. K.; Moro-Sibilot, Denis; Puri, Tarun; Varughese, Sunoj Chacko; Frimodt-Moller, Bente; Visseren-Grul, Carla; Reck, Martin Share Save
Real-world immunotherapy (IO) rechallenge outcomes with nivolumab (NIV) in advanced non-small cell lung cancer (aNSCLC) in France: LIST study interim results Godbert, B.; Gobbini, E.; Zysman, M.; Decroisette, C.; Lena, H.; Moro-Sibilot, D.; Guisier, F.; Egenod, T.; Couraud, S.; Brellier, F.; Fleuriet, A.; Khalife, Y.; Girard, N. Share Save
Preliminary clinical results of a therapeutic cancer vaccine PDC*lung01 in combination with anti-PD-1 in patients (pts) with stage IV NSCLC Theelen, Willemijn; Perol, Maurice; Cuppens, Kristof; Demedts, Ingel; Borm, Frank; Biesma, Bonne; Wauters, Els; Colinet, Benoit; Buchmeier, Eva-Lotte; Althoff, Friederike; Pons-Tostivint, Elvire; Van de Kerkhove, Charlotte; Moro-Sibilot, Denis; Sibille, Anne; Derijcke, Sofie; Skrzypski, Marcin; Plumas, Joel; De Vos, Beatrice; Debruyne, Channa; Cantero, Frederique; Adriaenssens, Stefanie; Renard, Florence; Vansteenkiste, Johan Share Save
PDC*lung01: An innovative therapeutic cancer vaccine induces specific immune responses in combination with anti- PD-1 treatment in patients with non-small cell lung cancer Plumas, Joel; Sibille, Anne; Demedts, Ingel; Pons-Tostivint, Elvire; Van de Kerkhove, Charlotte; Derijcke, Sofie; Theelen, Willemijn; Biesma, Bonne; Borm, Frank; Wauters, Els; Collodoro, Mike; Al Badawy, Kays; Duchayne, Camille; Debruyne, Channa; Devos, Beatrice; Colinet, Benoit; Moro-Sibilot, Denis; Perol, Maurice; Buchmeier, Eva-Lotte; Skrzypski, Marcin; Cuppens, Kristof; Vansteenkiste, Johan Share Save
Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer Drilon, Alexander; Camidge, D. Ross; Lin, Jessica J.; Kim, Sang-We; Solomon, Benjamin J.; Dziadziuszko, Rafal; Besse, Benjamin; Goto, Koichi; de Langen, Adrianus Johannes; Wolf, Juergen; Lee, Ki Hyeong; Popat, Sanjay; Springfeld, Christoph; Nagasaka, Misako; Felip, Enriqueta; Yang, Nong; Velcheti, Vamsidhar; Lu, Shun; Kao, Steven; Dooms, Christophe; Krebs, Matthew G.; Yao, Wenxiu; Beg, Muhammad Shaalan; Hu, Xiufeng; Moro-Sibilot, Denis; Cheema, Parneet; Stopatschinskaja, Shanna; Mehta, Minal; Trone, Denise; Graber, Armin; Sims, Gregory; Yuan, Yong; Cho, Byoung Chul Share Save
Share Save
BrigAlec study: Focus on alectinib efficacy after brigatinib exposure in BrigALK2 study (GFPC 02-2019) Descourt, R.; Guisier, F.; Perol, M.; Cadranel, J.; Duruisseaux, M.; Doubre, H.; Culine, S.; Lamour, C.; Moro-Sibilot, D.; Mennecier, B.; Martin, N.; Bylicki, O.; Chouaid, C.; Greillier, L. Share Save
VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop (vol 38, pg 1050, 2018) Boudria, Asma; Abou Faycal, Cherine; Jia, Tao; Gout, Stephanie; Keramidas, Michelle; Didier, Chloe; Lemaitre, Nicolas; Manet, Sandra; Coll, Jean-Luc; Toffart, Anne-Claire; Moro-Sibilot, Denis; Albiges-Rizo, Corinne; Josserand, Veronique; Faurobert, Eva; Brambilla, Christian; Brambilla, Elisabeth; Gazzeri, Sylvie; Eymin, Beatrice Share Save
Share Save
Lorlatinib for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer: Results of the IFCT-1803 LORLATU cohort Baldacci, Simon; Besse, Benjamin; Avrillon, Virginie; Mennecier, Bertrand; Mazieres, Julien; Dubray-Longeras, Pascale; Cortot, Alexis B.; Descourt, Renaud; Doubre, Helene; Quantin, Xavier; Duruisseaux, Michael; Monnet, Isabelle; Moro-Sibilot, Denis; Cadranel, Jacques; Clement-Duchene, Christelle; Cousin, Sophie; Ricordel, Charles; Merle, Patrick; Otto, Josiane; Schneider, Sophie; Langlais, Alexandra; Morin, Franck; Westeel, Virginie; Girard, Nicolas Share Save
Share Save
Lorlatinib for advanced ROS1+non-small-cell lung cancer: results of the IFCT-1803 LORLATU study Girard, N.; Galland-Girodet, S.; Avrillon, V; Besse, B.; Duruisseaux, M.; Cadranel, J.; Otto, J.; Prevost, A.; Roch, B.; Bennouna, J.; Bouledrak, K.; Coudurier, M.; Egenod, T.; Lamy, R.; Ricordel, C.; Moro-Sibilot, D.; Odier, L.; Tillon-Strozyk, J.; Zalcman, G.; Missy, P.; Westeel, V; Baldacci, S. Share Save
A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT-0701 MAPS phase 3 trial Maille, Elodie; Levallet, Jerome; Dubois, Fatemeh; Antoine, Martine; Danel, Claire; Creveuil, Christian; Mazieres, Julien; Margery, Jacques; Greillier, Laurent; Gounant, Valerie; Moro-Sibilot, Denis; Molinier, Olivier; Lena, Herve; Monnet, Isabelle; Bergot, Emmanuel; Langlais, Alexandra; Morin, Franck; Sherpereel, Arnaud; Zalcman, Gerard; Levallet, Guenaelle Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
